Abstract:Abstract Spontaneous T cell-inflamed tumor microenvironment is associated with clinical responses to immunotherapies, including immune checkpoint blockades. However, majority of established tumors often inhibit peripheral T cells entering tumor tissues for tumor destruction and/or prevent effective T cell priming. Previous studies in our lab have shown that upregulation of the tumor necrosis factor superfamily member LIGHT (also known as TNFSF14) in peripheral tissues results in T cell activation and migration into non-lymphoid tissues and formation of lymphoid-like structures, which lead to rapid T cell-mediated tissue destruction. Furthermore, local expression of LIGHT by tumor cells may promote the formation of lymphoid-like structures for direct T-cell sequestration and activation, leading to tumor regression. Those data suggest LIGHT as an interesting candidate to create T cell-inflamed tumor environment. To better evaluate the therapeutic efficacy of human LIGHT protein in both murine and human systems, we engineered human LIGHT by random mutation using yeast-display system, and were able to generate a human LIGHT mutant which binds to both murine and human receptors while remains stable. To specifically target LIGHT to tumor tissues, an antibody-LIGHT fusion protein was generated. In different mouse models, we found that antibody-LIGHT induces a T cell inflamed tumor environment. This is correlated with an upregulation of inflammatory cytokines and adhesion molecules, and leads to the rejection of established tumors. More importantly, we observed that LIGHT-mediated T cell inflamed environment is critical for restoring the efficacy of checkpoint blockade therapy. When we blocked lymphocyte trafficking, a tumor previously responding to checkpoint blockade became resistant to therapy. This process can be reversed by treating with LIGHT. Our study indicates that targeting LIGHT may be an effective strategy for cancer immunotherapy, especially those who do not response to checkpoint blockade due to the lack of infiltration. Citation Format: Haidong Tang, Yang Wang, Yang-Xin Fu. Increase lymphocyte infiltration overcomes tumor resistance to checkpoint blockade. [abstract]. In: Proceedings of the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2016;4(1 Suppl):Abstract nr A088.

Modulation of T-cell-mediated Immunity in Tumor and Graft-Versus-host Disease Models Through the LIGHT Co-Stimulatory Pathway.

Immunoregulation by tumor necrosis factor superfamily member LIGHT.

The Regulation of T Cell Homeostasis and Autoimmunity by T Cell–derived LIGHT

Promoting Immune Responses by LIGHT in the Face of Abundant Regulatory T Cell Inhibition

Induction of potent anti-tumor immunity by direct injection of Ad-LIGHT at the site of tumor inoculation.

Abstract A088: Increase Lymphocyte Infiltration Overcomes Tumor Resistance to Checkpoint Blockade

LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment

Targeting tumors with LIGHT to generate metastasis-clearing immunity.

Creating a T cell-inflamed tumor microenvironment overcomes resistance to checkpoint blockade

The Role of LIGHT in T Cell-Mediated Immunity

NK-cell Activation by LIGHT Triggers Tumor-Specific CD8+ T-cell Immunity to Reject Established Tumors.

Shining a LIGHT on myeloid cell targeted immunotherapy

Selective Targeting of the LIGHT-HVEM Costimulatory System for the Treatment of Graft-Versus-host Disease

The Complementation of Lymphotoxin Deficiency with LIGHT, a Newly Discovered TNF Family Member, for the Restoration of Secondary Lymphoid Structure and Function.

Adeno-associated virus-mediated local delivery of LIGHT suppresses tumorigenesis in a murine cervical cancer model.

The critical role of LIGHT, a TNF family member, in T cell development.

Blockade of LIGHT/LTβ and CD40 Signaling Induces Allospecific T Cell Anergy, Preventing Graft-Versus-host Disease

Essential Role of TNF Family Molecule LIGHT As a Cytokine in the Pathogenesis of Hepatitis

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade

Priming of Naive T Cells Inside Tumors Leads to Eradication of Established Tumors

Light Regulates Inflamed Draining Lymph Node Hypertrophy